NeuroSense
-
Neurowave strikes European distribution deal with CareFusion
Medical device startup NeuroWave Systems Inc. has reached a deal in which CareFusion (NYSE: CFN) will distribute NeuroWave’s brain-activity monitoring system in Germany and Scandinavia. It’s an important step for Cleveland Heights, Ohio-based NeuroWave, which in June received European regulatory clearance to begin selling its NeuroSense brain monitor for assessing anesthesia levels.
-
NeuroWave Systems gets FDA clearance for brain-monitoring system
Medical device startup NeuroWave Systems Inc. has received regulatory clearance from the Food and Drug Administration to begin selling a brain-activity monitoring system. The Cleveland Heights, Ohio-based company’s NeuroFAST Monitoring System is intended for use in hospital operating rooms, emergency departments and intensive care units with patients who’ve experienced some sort of brain trauma, such as seizures.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
NeuroWave Systems gets European nod to sell anesthesia monitor
Medical device startup NeuroWave Systems Inc. has received the CE marking for its NeuroSense anesthesia […]